Abstract
Objective
Chalcones (1, 3-diaryl-2-propen-1-ones) and their derivatives are widely explored from the past decade for its antimalarial activity. To elucidate their mechanism of action on the malaria parasite, the ultrastructural changes with the action of these derivatives in different organelles of the parasite were studied in vitro. Infected RBCs [CQ sensitive (MRC-2) and CQ resistant (RKL-9) Plasmodium strain] were treated with three chalcone derivatives 1, 2 and 3 and standard drugs, i.e., CQ and artemisinin at twice their respective IC50 values for 24 h and then harvested, washed, fixed, embedded and stained to visualize ultra-structure changes before and after intervention of treatment under in vitro condition through transmission electron microscope.
Results
The ultrastructural changes demonstrate the significant disturbance of all parasite membranes, including those of the nucleus, mitochondria and food vacuole, in association with a marked reduction of ribosomes in the trophozoites and cessation of developing schizonts which suggest multiple mechanisms of action by which chalcone derivatives act on the malaria parasite. The present study opens up perspectives for further exploration of these derivatives in vivo malaria model to discover more about its effect and mechanism of action.
Keywords: Plasmodium falciparum, Transmission electron microscopy, Chalcones, Malaria, In vitro
Introduction
Malaria caused by Plasmodium falciparum species is the most noxious as they can infect all RBCs irrespective of their ages. The species is also most prevalent in the WHO African Region, leading to almost 99.7% malaria cases in 2018 [1]. Although there is a significant reduction in the number of malaria-infected cases and deaths over years of successful efforts through the malaria elimination programme, at the same time with the persistence evidence of growing P. falciparum resistance to artemisinin has led to a global threat [2–5]. Therefore, it is crucial to discover some fresh antimalarial drug entities which have the quality of effectiveness as well as efficiency towards malaria treatment [6] and can counter the rapidity of the drug resistance phenomenon of the parasite.
Chalcones (1,3-diaryl-2-propen-1-ones), a plant secondary metabolites is well known for its diverse pharmacological activity [7–9], including antimalarial activity [10]. It can also offer a huge repository of bioactive compounds with enormous molecular targets [11]. Earlier our group has reported three potent chalcone derivatives 1, 2 and 3 with antimalarial activity, screened from a series of recently synthesized chalcone derivatives under in vitro conditions on both chloroquine-sensitive and chloroquine-resistant strains of Plasmodium. The study revealed even minor structural changes can increase the activity of a particular pharmacophore. Additionally, these derivatives act on the haeme degradation pathway of the malaria parasite, i.e., in a similar way as chloroquine does [11]. However, to better understand the effect and the mechanism by which these derivatives act on P. falciparum, an ultrastructure study was performed using the in vitro culture system.
Main text
Materials and methods
Parasites
The CQ-sensitive (MRC-2) and CQ-resistant (RKL-9) P. falciparum strains were maintained aseptically in continuous culture as mentioned earlier [12]. The P. falciparum culture was nurtured in A+ erythrocytes at 5% haematocrit. The complete culture medium consisted of RPMI 1640 (with glutamine, but without NaHCO3), constituted of 5.94 g/L of HEPES buffer, 1.00 g/L dextrose, 40.00 mg/L of gentamycin. In addition, supplemented with 5% NaHCO3 and 10% (v/v) inactivated human AB+ serum. Parasite cultures were kept at 37 °C with 90% N2, 5% O2 and 5% CO2, and the culture medium was changed at the interval of 22–24 h. Parasites were synchronized to the ring stage using 5% d-sorbitol as described previously [13]. Parasite growth and multiplication were checked by thin smear Giemsa stained slides using a light microscope.
Drugs and drug exposure
The three chalcone derivatives 1, 2 and 3 were synthesized as described previously by our group [11]. Chloroquine phosphate was obtained from Sigma Aldrich and artemisinin from IPCA. Stock solutions of three chalcone derivatives, chloroquine phosphate and artemisinin were separately prepared by dissolving each one of them in the diluted concentration of DMSO (1%) to attain a concentration of 1.00 mg/mL.
Before each experiment, cultures were expanded in sterile cell culture plates, maintaining less than 5% parasitaemia in 5% haematocrit. A non-treated negative control was maintained separately in a different plate at the same culture condition, i.e., at 37 °C, 5% CO2, 90% N2, 5% O2. The ring-stage parasite-infected RBCs (strain MRC-2 & RKL-9) were exposed to different drugs for 24 h at twice their respective IC50 values given in Table 1. After drug exposure, the iRBC were washed and lysed with 1X RBC lysis buffer to release parasite, which was further processed for transmission electron microscopy to assess parasite ultrastructure.
Table 1.
Drugs/compound name | Structure | Series name | MRC-2 (P. falciparum CQS strain) IC50 (µg/mL) | RKL-9 (P. falciparum CQR strain) IC50 (µg/mL) |
---|---|---|---|---|
(E)-1-(2,5-Dimethoxyphenyl)-3-(4-methoxyphenyl)prop-2-en-1-one | 1 | O.13 | 0.14 | |
(E)-(3,4,5-Trimethoxyphenyl)-3-(4-methoxyphenyl)prop-2-en-1-one | 2 | 0.35 | 0.19 | |
(E)-1-(3,4,5-Trimethoxyphenyl)-3-(3,4-dimethoxyphenyl)prop-2-en-1-one | 3 | 0.11 | 0.18 | |
CQ | – | NA | 0.17 | ND |
Artemisinin (ng/mL) | – | NA | ND | 0.15 |
CQ chloroquine, CQS chloroquine sensitive, CQR chloroquine resistant, NA not applicable, ND not determine
Transmission electron microscopy
Control and drug-treated parasites were washed with 1X PBS and suspended for 24 h with a mixture of a solution containing glutaraldehyde (2.5%) and paraformaldehyde (4%) in cacodylate buffer (0.1 M) having pH 7.2, followed by post-fixing with a mixture of osmium tetroxide (1% OsO4) and potassium ferrocyanide (0.8%) in cacodylate buffer (0.1 M). The pellet down cells were then dehydrated in a graded concentration of acetone and embedded in Epoxy resin (EPON mixture with DMP in rubber moulds). Further kept for polymerization at 60 °C for 24 h. Ultra-thin sections were cut on Ultracut-E ultramicrotome (Reichert-Jung, Germany) using a diamond knife and mounted on copper grids. The sections were double-stained with uranyl acetate and lead citrate and visualized in a ZEISS EM900 and in a JEOL 1200EX transmission electron microscope.
Results and discussion
In a search for novel compounds that would be effective blood schizonticides against both CQ sensitive and resistant P. falciparum, the action of chalcones derivatives at an ultra-structural level under in vitro conditions was studied. Infected RBCs [CQ sensitive (MRC-2) and CQ resistant (RKL-9) Plasmodium strain] were incubated without drug, taken as negative control, and treated with three chalcone derivatives 1, 2 and 3 and standard CQ and artemisinin taken as positive control for CQ sensitive (MRC-2) and CQ resistant (RKL-9) strain at twice their respective IC50 values for 24 h and then harvested, washed, fixed, embedded and stained to visualize ultra-structure changes before and after intervention of treatment under in vitro condition on both the Plasmodium strain through transmission electron microscope. Released Plasmodium from lysed RBC has shown in (Additional file 1: Figure S1).
At the ultrastructural level, the most conspicuous changes are seen in trophozoites at all stages of development. After 24 h of drug exposure, the mitochondria were swollen and there was the loss of membranes integrity. The endoplasmic reticulum is less conspicuous and ribosome numbers are markedly decreased (Fig. 1c–j) compared with parasites of the same stage from untreated control, having cytoplasm with well-distributed ribosomes and a clearly defined nucleus. However, food vacuole was well integrated on CQ treatment as compared to chalcones shown in (Fig. 1c, d).
Although the parasites are advancing towards schizogony, this process is being blocked. In Fig. 2. RKL-9 (c–j), the nuclear membranes appear to have completely disappeared in places, making it difficult to distinguish between nuclear contents and the general cytoplasm. There is also a marked loss of endoplasmic reticulum and of ribosome density and content, especially in the parasite shown in Fig. 2. RKL-9 (d–j). In both types, mitochondria are distended, nuclear membranes blebbed, and ribosomes are reduced. Numerous ribosomes are still visible but irregularly distributed within the cytoplasm which lacks the endoplasmic reticulum. Swollen mitochondria with varying degree of membrane irregularities is seen which shows similar results as compared with earlier report done on Leishmania parasite under the effect of oxygenated chalcones licochalcone A [14] and 2,4-dimethoxy-4′-butoxy-chalcone [15]. The peripheral parasite membrane is also partially disrupted, as is the membrane of the pigment vesicles. A major feature was the appearance of large vacuoles (Figs. 1 and 2d–j). Schizogony has been interrupted. The process of merozoite membrane formation, both peripherally and around the nuclei, is clearly interrupted. The ultrastructural changes demonstrate the significant disturbance of all parasite membranes, including those of the nucleus, mitochondria, and endoplasmic reticulum, in association with a marked reduction of ribosomes in the trophozoites and developing schizonts which is supported by previous studies where drugs like artemisinin, dipyridamole, artesunate, quinine, and piperaquine showed more or less similar effects [16–18]. However, loss of knobs on drug treatment was not observed in both the Plasmodium strains due to RBC-free parasite. Knobs present on P. falciparum responsible for carrying antigens which benefit in parasite sequestration, would explain virulence and cytoadhesion ability [19]. Also, the food vacuole was intact but in condensed form in case of CQ-treated parasite, however, chalcone-treated parasites showed disintegrated food vacuole in mostly both CQ-sensitive and CQ-resistant strain. Additionally, evidence of darkly stained food vacuole in electron micrograph (Additional file 2: Figure S2) reveals interference in the haemoglobin degradation which ultimately lead to the death of the parasite [20]. Thus, suggest food vacuole may be the optimum target for chalcones which is further supported by our previous finding on significant reduction in hemozoin formation after chalcone treatment [11].
Conclusion
Chalcones and their derivatives are important scaffolds for providing various potent leads. The present ultrastructure study indicates food vacuole as the chief target site of these chalcone derivatives. However, the disintegration of other organelles, chromatin condensation and a marked reduction in ribosomes provide evidence about multiple mechanisms by which these chalcones exert its antiparasitic effect and it needs to be further validated through various biochemical, molecular and proteomics tools. Also, there is no such published study concerning the ultrastructural alteration induced on chalcone or chalcone derivative treatment on malaria parasite. Henceforth, the present study opens up perspectives for further exploration of these derivatives in vivo malaria models to discover more about its effect and mechanism of action.
Limitations
The stage dependent growth inhibition as well as time dependent growth inhibition of the parasite was not evaluated in the current study, which may provide clarity of kinetic and morphological changes inside the parasite under the influence of these chalcone derivatives.
Supplementary information
Acknowledgements
We are thankful to Indian Council of Medical Research (ICMR), New Delhi for providing financial support in form of junior research fellowship and senior research fellowship to Shweta Sinha.
Abbreviations
- CQ
Chloroquine
- DMSO
Dimethyl sulfoxide
- HEPES
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
- IC50
The half maximal inhibitory concentration
- NaHCO3
Sodium bicarbonate
- PBS
Phosphate buffer saline
- RBC
Red Blood Cell
Authors’ contributions
SS, RS, BM, BDR designed the study. SS and BDR performed experiments and analysis. DIB and NM contributed reagents and materials. SS, RS and BDR helped in the writing, reviewing, and editing of the manuscript. All authors read and approved the final manuscript.
Funding
No funding support has been provided in the design of the studies, data collection, analysis, interpretation of data and in writing of the manuscript from any funding agencies (public, commercial, or not-for-profit sectors).
Availability of data and materials
All data generated or analyzed during this study are included in this published article and its additional information files.
Ethical approval and consent to participate
The ethical approval was taken from Institute Ethics Committee, Project No. NK/1265/Ph.D/23991 at Post Graduate Institute of Medical Education and Research, Chandigarh, India for maintenance of P. falciparum strains in A/B+ ve erythrocytes and AB +ve human serum.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Footnotes
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Supplementary information accompanies this paper at 10.1186/s13104-020-05132-z.
References
- 1.WHO. World malaria report 2019. Geneva: World Health Organization. http://www.who.int/malaria/publications/world-malariareport-2019/en/. Accessed 10 Feb 2020.
- 2.Noedl H, Se Y, Schaecher K, Smith BL, Socheat D, Fukuda MM. Artemisinin Resistance in Cambodia 1 (ARC1) Study Consortium. Evidence of artemisinin-resistant malaria in western Cambodia. N Engl J Med. 2008;359:2619–2620. doi: 10.1056/NEJMc0805011. [DOI] [PubMed] [Google Scholar]
- 3.Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, Lwin KM, Ariey F, Hanpithakpong W, Lee SJ, et al. Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2009;361:455–467. doi: 10.1056/NEJMoa0808859. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Ashley EA, Dhorda M, Fairhurst RM, Amaratunga C, Lim P, Suon S, Sreng S, Anderson JM, Mao S, Sam B, Tracking Resistance to Artemisinin Collaboration et al. Spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2014;371:411–423. doi: 10.1056/NEJMoa1314981. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Miotto O, Amato R, Ashley EA, MacInnis B, Almagro-Garcia J, Amaratunga C, Lim P, Mead D, Oyola SO, Dhorda M, et al. Genetic architecture of artemisinin-resistant Plasmodium falciparum. Nat Genet. 2015;47:226–234. doi: 10.1038/ng.3189. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Wells T, van Huijsduijnen R, Van Voorhis W. Malaria medicines: a glass half full? Nat Rev Drug Discov. 2015;14:424–442. doi: 10.1038/nrd4573. [DOI] [PubMed] [Google Scholar]
- 7.Nowakowska Z. A review of anti-infective and antiinflammatory chalcones. Eur J Med Chem. 2007;42:125–137. doi: 10.1016/j.ejmech.2006.09.019. [DOI] [PubMed] [Google Scholar]
- 8.Batovska DI, Todorova IT. Trends in utilization of the pharmacological potential of chalcones. Curr Clin Pharmacol. 2010;5:1–29. doi: 10.2174/157488410790410579. [DOI] [PubMed] [Google Scholar]
- 9.de Mello TF, Bitencourt HR, Pedroso RB, Aristides SM, Lonardoni MV, Silveira TG. Leishmanicidal activity of synthetic chalcones in Leishmania (Viannia) braziliensis. Exp Parasitol. 2014;136:27–34. doi: 10.1016/j.exppara.2013.11.003. [DOI] [PubMed] [Google Scholar]
- 10.Sinha S, Medhi B, Sehgal R. Chalcones as an emerging lead molecule for antimalarial therapy: a review. J Mod Med Chem. 2013;1:64–77. [Google Scholar]
- 11.Sinha S, Batovska DI, Medhi B, Radotra BD, Bhalla A, Markova N, Sehgal R. In vitro anti-malarial efficacy of chalcones: cytotoxicity profile, mechanism of action and their effect on erythrocytes. Malar J. 2019;8:421. doi: 10.1186/s12936-019-3060-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Trager W, Jensen JB. Human malaria parasites in Continuous culture. Science. 1976;93:673–675. doi: 10.1126/science.781840. [DOI] [PubMed] [Google Scholar]
- 13.Lambros C, Vanderberg JP. Synchronization of P. falciparum erythrocytic stages in culture. J Parasitol. 1979;65:418–420. doi: 10.2307/3280287. [DOI] [PubMed] [Google Scholar]
- 14.Zhai L, Blom J, Chen M, Christensen SB, Kharazmi A. The antileishmanial agent licochalcone A interferes with the function of parasite mitochondria. Antimicrob Agents Chemother. 1995;39(12):2742–2748. doi: 10.1128/AAC.39.12.2742. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Zhai L, Chen M, Blom J, Theander TG, Christensen SB, Kharazmi A. The antileishmanial activity of novel oxygenated chalcones and their mechanism of action. J Antimicrob Chemother. 1999;43(6):793–803. doi: 10.1093/jac/43.6.793. [DOI] [PubMed] [Google Scholar]
- 16.Maeno Y, Toyoshima T, Fujioka H, Ito Y, Meshnick SR, Benakis A, Milhous WK, Aikawa M. Morphologic effects of artemisinin in Plasmodium falciparum. Am J Trop Med Hyg. 1993;49:485–491. doi: 10.4269/ajtmh.1993.49.485. [DOI] [PubMed] [Google Scholar]
- 17.Akaki M, Nakano Y, Ito Y, Nagayasu E, Aikawa M. Effects of dipyridamole on Plasmodium falciparum-infected erythrocytes. Parasitol Res. 2002;88:1044–1050. doi: 10.1007/s00436-002-0690-8. [DOI] [PubMed] [Google Scholar]
- 18.Sachanonta N, Chotivanich K, Chaisri U, Turner GD, Ferguson DJ, Day NP, Pongponratn E. Ultrastructural and real-time microscopic changes in P. falciparum-infected red blood cells following treatment with antimalarial drugs. Ultrastruct Pathol. 2011;35:214–225. doi: 10.3109/01913123.2011.601405. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Rug M, Prescott SW, Fernandez KM, Cooke BM, Cowman AF. The role of KAHRP domains in knob formation and cytoadherence of P falciparum-infected human erythrocytes. Blood. 2006;108:370–378. doi: 10.1182/blood-2005-11-4624. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Pulcini S, Staines HM, Lee AH, Shafik SH, Bouyer G, Moore CM, Daley DA, Hoke MJ, Altenhofen LM, Painter HJ, et al. Mutations in the Plasmodium falciparum chloroquine resistance transporter, PfCRT, enlarge the parasite’s food vacuole and alter drug sensitivities. Sci Rep. 2015;5:14552. doi: 10.1038/srep14552. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
All data generated or analyzed during this study are included in this published article and its additional information files.